MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijid.2021.12.343

Медицинская библиотека · International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021

Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.

McKinnon John E, Wang Dee Dee, Zervos Marcus, Saval Matt, Marshall-Nightengale Laurie, Kilgore Paul, Pabla Pardeep, Szandzik Ed, Maksimowicz-McKinnon Kathleen, O'Neill William W

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Health care workers (HCW) are among the highest risk groups for acquisition of COVID-19 because of occupational exposures. The WHIP COVID-19 Study aimed to evaluate the safety and efficacy of hydroxychloroquine (HCQ) as chemoprophylaxis for SARS-CoV-2 infection in this population.

METHODS

HCW, first responders, and other occupationally high-risk participants were enrolled in a randomized, placebo-controlled clinical study of HCQ from April to October 2020. The trial compared daily versus weekly HCQ with placebo and with a prospective cohort on HCQ for autoimmune diseases. Participants were followed for 8 weeks. Serology or a positive polymerase chain reaction test was used to determine laboratory confirmed clinical cases.

RESULTS

A total of 624 participants were randomized to placebo (n = 200), weekly HCQ (n = 201), daily HCQ (n = 197). For the primary safety end point, 279 (44.7%) participants experienced adverse event (AE) level II or lower (total AEs n = 589), similar rates in all randomized groups (P = .188) with no hospitalizations or interventions required. Only 4 laboratory confirmed COVID-19 cases occurred, with 2 in the placebo arm and one in each HCQ randomized arm.

CONCLUSIONS

This randomized placebo-controlled trial was able to demonstrate the safety of HCQ outpatient chemoprophylaxis in high-risk groups against COVID-19. Future studies of chemoprophylaxis for SARS-CoV-2 are needed as the epidemic continues worldwide.

Для цитирования: McKinnon John E, Wang Dee Dee, Zervos Marcus, Saval Matt, Marshall-Nightengale Laurie, Kilgore Paul, Pabla Pardeep, Szandzik Ed, Maksimowicz-McKinnon Kathleen, O'Neill William W. Safety and tolerability of hydroxychloroquine in health care workers and first responders for the prevention of COVID-19: WHIP COVID-19 Study.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2021. DOI: 10.1016/j.ijid.2021.12.343.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.